A Case of Insulinoma With Provoked Seizures for the Past Fourteen Years: A Case Report
Archives of Critical Care Medicine,
Vol. 1 No. 4 (2016),
28 October 2023
Abstract
Introduction: Insulinoma is one of the most common neuro-endocrine tumors of the pancreas. Some cases with insulinoma present neuropsychiatric symptoms and are often misdiagnosed as psychosis thus patients may remain symptomatic from one week to as long as several decades before diagnosis.
Case Presentation: A 68-year-old male patient, who presented episodic seizures and a normal Electroencephalography (EEG) recording for the past fourteen years, had referred for evaluation of hypoglycemia. His biochemical profile revealed blood glu[1]cose of 45mg/dL. His C-peptide and insulin levels were elevated. Endoscopic pancreatic ultrasonography (EUS) revealed two mass lesions in pancreatic head. Pathological evaluation revealed well-differentiated endocrine neoplasm and granulomatous reaction in lymph nodes. After resection of the tumor, his symptoms resolved and he became seizure free.
Conclusions: Some cases with insulinoma that present neuropsychiatric symptomsmight remain symptomatic for several decades before diagnosis. Therefore, it is important for physicians to be aware of presentations of insulinoma to avoid diagnostic delays.
- Seizure
- Insulinoma
- Hypoglycemia
How to Cite
References
Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau JW, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J
Clin Endocrinol Metab. 2009;94(4):1069–73. doi: 10.1210/jc.2008-2031.
[PubMed: 19141587].
Service FJ, Natt N. The prolonged fast. J Clin Endocrinol Metab.
;85(11):3973–4. doi: 10.1210/jcem.85.11.6934. [PubMed: 11095416].
Vezzosi D, Bennet A, Fauvel J, Caron P. Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. Eur J Endocrinol. 2007;157(1):75–83. doi:
1530/EJE-07-0109. [PubMed: 17609405].
Noone TC, Hosey J, Firat Z, Semelka RC. Imaging and localization of
islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin
Endocrinol Metab. 2005;19(2):195–211. doi: 10.1016/j.beem.2004.11.013.
[PubMed: 15763695].
Grossman AB, Reznek RH. Commentary: imaging of islet-cell tumours. Best Pract Res Clin Endocrinol Metab. 2005;19(2):241–3. doi:
1016/j.beem.2004.11.002. [PubMed: 15763698].
Virgolini I, Traub-Weidinger T, Decristoforo C. Nuclear medicine
in the detection and management of pancreatic islet-cell tumours. Best Pract Res Clin Endocrinol Metab. 2005;19(2):213–27. doi:
1016/j.beem.2004.09.001. [PubMed: 15763696].
Kumbasar B, Kamel IR, Tekes A, Eng J, Fishman EK, Wahl RL. Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS.
Abdom Imaging. 2004;29(6):696–702. doi: 10.1007/s00261-003-0162-3.
[PubMed: 15162235].
Fritscher-Ravens A. Endoscopic ultrasound and neuroendocrine tumours of the pancreas. JOP. 2004;5(4):273–81. [PubMed: 15254362].
Pasieka JL, McLeod MK, Thompson NW, Burney RE. Surgical approach
to insulinomas. Assessing the need for preoperative localization. Arch
Surg. 1992;127(4):442–7. [PubMed: 1558498].
Thompson NW, Czako PF, Fritts LL, Bude R, Bansal R, Nostrant TT, et al.
Role of endoscopic ultrasonography in the localization of insulinomas and gastrinomas. Surgery. 1994;116(6):1131–8. [PubMed: 7985098].
Grant CS. Surgical aspects of hyperinsulinemic hypoglycemia. Endocrinol Metab Clin North Am. 1999;28(3):533–54. [PubMed: 10500930].
Doherty GM, Doppman JL, Shawker TH, Miller DL, Eastman RC, Gorden
P, et al. Results of a prospective strategy to diagnose, localize, and resect insulinomas. Surgery. 1991;110(6):989–96. [PubMed: 1745987].
Mittendorf EA, Liu YC,McHenry CR. Giant insulinoma: case report and
review of the literature. J Clin Endocrinol Metab. 2005;90(1):575–80.
doi: 10.1210/jc.2004-0825. [PubMed: 15522939].
Shlomo M, Kenneth SP, Reed L, Henry MK. Williams textbook of Endocrinilogy. 13 ed. Elsevier; 2015.
- Abstract Viewed: 8 times
- PDF Downloaded: 0 times